National Utilization Trends of Inpatient Procedures for Symptomatic Uterine Fibroids and Adenomyosis: A 10-Year Analysis

other OA: bronze public-domain-us
⚙ AI-generated summary by qwen3.7-flash, 2026-08-25 ⓘ

This 10-year analysis of inpatient procedures found that while hysterectomy remains the dominant treatment for uterine fibroids and adenomyosis, myomectomy utilization increased for fibroids, whereas uterine artery embolization remained stable and underutilized.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-18 · read from full text ⓘ

This paper used a 10-year analysis of national inpatient data to examine utilization trends of inpatient procedures performed for symptomatic uterine fibroids and adenomyosis, assessing how procedure patterns changed over time. The authors focused on inpatient procedure utilization at the national level, describing overall trends and relevant shifts in the types of procedures used for these diagnoses. A major caveat is that administrative inpatient databases capture procedure utilization without clinical detail, limiting the ability to determine appropriateness, symptom severity, or indications driving specific treatment choices. This paper is centrally about endometriosis and/or adenomyosis—specifically adenomyosis—because it quantifies national utilization trends for inpatient procedures for symptomatic uterine fibroids and adenomyosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

PURPOSE: The aim of this study was to determine changes in procedural utilization for symptomatic uterine fibroids and adenomyosis from 2011 to 2020. METHODS: An institutional review board-exempt retrospective study of the National Inpatient Sample database from 2011 to 2020 was performed using International Classification of Diseases, Ninth Revision, and International Classification of Diseases, 10th Revision, diagnosis and procedural codes for uterine fibroids, adenomyosis, hysterectomy, myomectomy, uterine artery embolization (UAE), and endometrial ablation. Patients with endometriosis, uterine cancer, placenta accreta spectrum, pelvic inflammatory disease, and uterine prolapse were excluded. Data were analyzed using statistical process control and χ2 testing. RESULTS: A total of 247,476 inpatient procedures were identified in women with fibroids and/or adenomyosis. Of those patients with only uterine fibroids (n = 212,532), 77.9% underwent hysterectomy, 18.9% underwent myomectomy, and 2.8% underwent UAE. The utilization of UAE remained stable over the decade, whereas an increased prevalence of myomectomy was offset by a decrease in hysterectomy (2011 versus 2020: hysterectomy, 81.4% versus 73.7%; myomectomy, 15.4% versus 24.0%; UAE, 2.9% versus 2.0%). Regarding adenomyosis only (n = 16,073), more women underwent hysterectomy (98.1%) compared with UAE (1.1%), with minimal change in these procedures across the decade. For combined fibroids and adenomyosis (n = 18,871), hysterectomy was the most utilized procedure, with its utilization declining from 92.0% to 85.2% during the time period. CONCLUSIONS: The utilization of hysterectomy remains the dominant inpatient procedural intervention for the treatment of uterine fibroids and adenomyosis, but the proportion of myomectomy in the setting of fibroids is increasing. Utilization of UAE did not change from 2011 to 2020, and it remains relatively underutilized despite initiatives to increase utilization.
Full text 8,573 characters · extracted from oa-html · click to expand
National Utilization Trends of Inpatient Procedures for Symptomatic Uterine Fibroids and Adenomyosis: A 10-Year Analysis Affiliations & Notes aDivision of Vascular and Interventional Radiology, Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina bErnest H. Wood Distinguished Professor & Chair, Division of Vascular and Interventional Radiology, Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina cDivision of Cancer Epidemiology, Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina dAssociate Professor, Vice Chair of Health Equity & Community Engagement, Division of Vascular and Interventional Radiology, Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina eAssistant Professor, Interventional Radiology Residency Program Director, Division of Vascular and Interventional Radiology, Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina Article Info Publication History: Published online December 9, 2024 Footnotes: The authors state that they have no conflict of interest related to the material discussed in this article. All authors are non-partner/non-partnership track/employees. DOI: 10.1016/j.jacr.2024.11.031 External LinkAlso available on ScienceDirect External Link Copyright: © 2024 American College of Radiology Linked Articles Download started OkVisual Abstract Key Words References 1. Viswanathan, M. ∙ Hartmann, K. ∙ McKoy, N. ... Management of uterine fibroids: an update of the evidence Evid Rep Technol Assess (Full Rep). 2007; 1-122 2. Herve, F. ∙ Katty, A. ∙ Isabelle, Q. ... Impact of uterine fibroids on quality of life: a national cross-sectional survey Eur J Obstet Gynecol Reprod Biol. 2018; 229:32-37 3. Kohi, M.P. ∙ Spies, J.B. Updates on uterine artery embolization Semin Intervent Radiol. 2018; 35:48-55 4. Dariushnia, S.R. ∙ Nikolic, B. ∙ Stokes, L.S. ..., Society of Interventional Radiology Standards of Practice Committee Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata J Vasc Interv Radiol. 2014; 25:1737-1747 5. de Bruijn, A.M. ∙ Smink, M. ∙ Lohle, P.N.M. ... Uterine artery embolization for the treatment of adenomyosis: a systematic review and meta-analysis J Vasc Interv Radiol. 2017; 28:1629-1642.e1 6. Stewart, E.A. ∙ Cookson, C.L. ∙ Gandolfo, R.A. ... Epidemiology of uterine fibroids: a systematic review BJOG. 2017; 124:1501-1512 7. Upson, K. ∙ Missmer, S.A. Epidemiology of adenomyosis Semin Reprod Med. 2020; 38:89-107 8. Divakar, H. Asymptomatic uterine fibroids Best Pract Res Clin Obstet Gynaecol. 2008; 22:643-654 9. Hasselrot, K. ∙ Lindeberg, M. ∙ Konings, P. ... Investigating the loss of work productivity due to symptomatic leiomyoma PLoS One. 2018; 13, e0197958 10. de Bruijn, A.M. ∙ Smink, M. ∙ Hehenkamp, W.J.K. ... Uterine artery embolization for symptomatic adenomyosis: 7-year clinical follow-up using UFS-Qol questionnaire Cardiovasc Intervent Radiol. 2017; 40:1344-1350 11. Management of symptomatic uterine leiomyomas ACOG practice bulletin, number 228 Obstet Gynecol. 2021; 137:e100-e115 12. Borah, B.J. ∙ Laughlin-Tommaso, S.K. ∙ Myers, E.R. ... Association between patient characteristics and treatment procedure among patients with uterine leiomyomas Obstet Gynecol. 2016; 127:67-77 13. Gupta, J.K. ∙ Sinha, A. ∙ Lumsden, M.A. ... Uterine artery embolization for symptomatic uterine fibroids Cochrane Database Syst Rev. 2014;, CD005073 14. Sandberg, E.M. ∙ Tummers, F. ∙ Cohen, S.L. ... Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis Fertil Steril. 2018; 109:698-707.e1 15. de Bruijn, A.M. ∙ Ankum, W.M. ∙ Reekers, J.A. ... Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial Am J Obstet Gynecol. 2016; 215:745.e1-745.e12 16. Wang, C. ∙ Kuban, J.D. ∙ Lee, S.R. ... Utilization of endovascular and surgical treatments for symptomatic uterine leiomyomas: a population health perspective J Vasc Interv Radiol. 2020; 31:1552-1559.e1 17. Meier, S.K. ∙ Pollock, B.D. ∙ Kurtz, S.M. ... State and government administrative databases: Medicare, National Inpatient Sample (NIS), and State Inpatient Databases (SID) programs J Bone Joint Surg Am. 2022; 104:4-8 18. Houchens, R. ∙ Ross, D. ∙ Elixhauser, A. ... Nationwide Inpatient Sample redesign final report Agency for Healthcare Research and Quality, Rockville, MD, 2014 19. Duclos, A. ∙ Voirin, N. The p-control chart: a tool for care improvement Int J Qual Health Care. 2010; 22:402-407 20. Marsh, E.E. ∙ Al-Hendy, A. ∙ Kappus, D. ... Burden, prevalence, and treatment of uterine fibroids: a survey of U.S. women J Womens Health (Larchmt). 2018; 27:1359-1367 21. Zurawin, R.K. ∙ Fischer, J.H.I.I. ∙ Amir, L. The effect of a gynecologist-interventional radiologist relationship on selection of treatment modality for the patient with uterine myoma J Minim Invasive Gynecol. 2010; 17:214-221 22. Spencer, E.B. ∙ Stratil, P. ∙ Mizones, H. Clinical and periprocedural pain management for uterine artery embolization Semin Intervent Radiol. 2013; 30:354-363 23. Duvnjak, S. ∙ Andersen, P.E. Intra-arterial lidocaine administration during uterine fibroid embolization to reduce the immediate postoperative pain: a prospective randomized study CVIR Endovasc. 2020; 3:10 24. Yoon, J. ∙ Valenti, D. ∙ Muchantef, K. ... Superior hypogastric nerve block as post-uterine artery embolization analgesia: a randomized and double-blind clinical trial Radiology. 2018; 289:248-254 25. Stewart, J.K. ∙ Patetta, M.A. ∙ Burke, C.T. Superior hypogastric nerve block for pain control after uterine artery embolization: effect of addition of steroids on analgesia J Vasc Interv Radiol. 2020; 31:1005-1009.e1 26. Ludwig, P.E. ∙ Huff, T.J. ∙ Shanahan, M.M. ... Pregnancy success and outcomes after uterine fibroid embolization: updated review of published literature Br J Radiol. 2020; 93, 20190551 27. Mohan, P.P. ∙ Hamblin, M.H. ∙ Vogelzang, R.L. Uterine artery embolization and its effect on fertility J Vasc Interv Radiol. 2013; 24:925-930 28. Mara, M. ∙ Maskova, J. ∙ Fucikova, Z. ... Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy Cardiovasc Intervent Radiol. 2008; 31:73-85 29. Zanolli, N.C. ∙ Bishop, K.C. ∙ Kuller, J.A. ... Fibroids and fertility: a comparison of myomectomy and uterine artery embolization on fertility and reproductive outcomes Obstet Gynecol Surv. 2022; 77:485-494 30. McEnteggart, G.E. ∙ Naeem, M. ∙ Skierkowski, D. ... Readability of online patient education materials related to IR J Vasc Interv Radiol. 2015; 26:1164-1168 31. Hansberry, D.R. ∙ Kraus, C. ∙ Agarwal, N. ... Health literacy in vascular and interventional radiology: a comparative analysis of online patient education resources Cardiovasc Intervent Radiol. 2014; 37:1034-1040 32. Trivedi, P.S. ∙ Guerra, B. ∙ Kumar, V. ... Healthcare disparities in interventional radiology J Vasc Interv Radiol. 2022; 33:1459-14567.e1 33. Marchak, K. ∙ Singh, D. ∙ Malavia, M. ... A review of healthcare disparities relevant to interventional radiology Semin Intervent Radiol. 2023; 40:427-436 34. Solberg, L.I. ∙ Asche, S.E. ∙ Sepucha, K. ... Informed choice assistance for women making uterine fibroid treatment decisions: a practical clinical trial Med Decis Making. 2010; 30:444-452 35. Harada, T. ∙ Khine, Y.M. ∙ Kaponis, A. ... The impact of adenomyosis on women’s fertility Obstet Gynecol Surv. 2016; 71:557-568 36. Buggio, L. ∙ Dridi, D. ∙ Barbara, G. Adenomyosis: impact on fertility and obstetric outcomes Reprod Sci. 2021; 28:3081-3084 37. Mailli, L. ∙ Patel, S. ∙ Das, R. ... Uterine artery embolisation: fertility, adenomyosis and size—what is the evidence? CVIR Endovasc. 2023; 6:8 38. de Bruijn, A.M. ∙ Lohle, P.N. ∙ Huirne, J.A. ... Uterine artery embolization versus hysterectomy in the treatment of symptomatic adenomyosis: protocol for the randomized QUESTA trial JMIR Res Protoc. 2018; 7:e47 39. Stewart, J.K. ∙ Myers, E. ∙ Petrozza, J. ... Reproductive outcomes of patients undergoing uterine artery embolization for uterine fibroids: proceedings from the Dr. James B. Spies Summit for Uterine Fibroid Research—a society of Interventional Radiology Foundation research consensus panel J Vasc Interv Radiol. 2024; 35:1288-1295

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisadenomyosis

MeSH descriptors

Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-09-27T06:03:42.939182+00:00
pubmed
last seen: 2026-09-26T06:12:21.691387+00:00
unpaywall
last seen: 2026-05-11T08:34:28.763810+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine